NO20012992D0 - Krystallinsk form av TRAP samt anvendelse derav for strukturbasert medikament-utforming - Google Patents

Krystallinsk form av TRAP samt anvendelse derav for strukturbasert medikament-utforming

Info

Publication number
NO20012992D0
NO20012992D0 NO20012992A NO20012992A NO20012992D0 NO 20012992 D0 NO20012992 D0 NO 20012992D0 NO 20012992 A NO20012992 A NO 20012992A NO 20012992 A NO20012992 A NO 20012992A NO 20012992 D0 NO20012992 D0 NO 20012992D0
Authority
NO
Norway
Prior art keywords
trap
crystalline form
drug design
based drug
design
Prior art date
Application number
NO20012992A
Other languages
English (en)
Other versions
NO20012992L (no
Inventor
Jonas Uppenberg
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of NO20012992D0 publication Critical patent/NO20012992D0/no
Publication of NO20012992L publication Critical patent/NO20012992L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20012992A 1998-12-18 2001-06-15 Krystallinsk form av TRAP samt anvendelse derav for strukturbasert medikament-utforming NO20012992L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9804418A SE9804418D0 (sv) 1998-12-18 1998-12-18 Crystal
PCT/SE1999/002192 WO2000037620A1 (en) 1998-12-18 1999-11-25 Crystalline form of activated trap and use thereof for structure-based drug design

Publications (2)

Publication Number Publication Date
NO20012992D0 true NO20012992D0 (no) 2001-06-15
NO20012992L NO20012992L (no) 2001-08-20

Family

ID=20413745

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20012992A NO20012992L (no) 1998-12-18 2001-06-15 Krystallinsk form av TRAP samt anvendelse derav for strukturbasert medikament-utforming

Country Status (8)

Country Link
EP (1) EP1141253A1 (no)
JP (1) JP2002533073A (no)
AU (1) AU767520B2 (no)
CA (1) CA2355830A1 (no)
NO (1) NO20012992L (no)
NZ (1) NZ512352A (no)
SE (1) SE9804418D0 (no)
WO (1) WO2000037620A1 (no)

Also Published As

Publication number Publication date
JP2002533073A (ja) 2002-10-08
NZ512352A (en) 2003-10-31
NO20012992L (no) 2001-08-20
CA2355830A1 (en) 2000-06-29
EP1141253A1 (en) 2001-10-10
WO2000037620A1 (en) 2000-06-29
AU767520B2 (en) 2003-11-13
AU1439000A (en) 2000-07-12
SE9804418D0 (sv) 1998-12-18

Similar Documents

Publication Publication Date Title
NO995852L (no) Ny form av S-omeprazol
PT1119557E (pt) Derivados de indeno- nafto- e benzociclohepta-di-hidrotiazole sua preparacao e sua utilizacao como medicamentos anorecticos
NO984852D0 (no) Nye benzazepinderivater, medikamenter inneholdende forbindelsene samt deres anvendelse ved fremstilling av medikamentene
DE50007243D1 (de) Säschar
DE69908021D1 (de) Ziprasidonhaltige Arzneimittel
NO20012915L (no) Ny farmasöytisk formulering
IT1298131B1 (it) Erogatore di sostanze pastose o cremose
NO20020365L (no) Oligonukleotider for inhibiering av ekspresjonen av humant eg5
EE04431B1 (et) Bensamidiini derivaadid ja nende kasutamine LTB-4antagonistliku mõjuga ravimitena
DE59904737D1 (de) Orale arzneiformen mit reproduzierbarer wirkstofffreisetzung von gatifloxacin oder pharmazeutisch verwendbaren salzen oder hydraten
NO20021090D0 (no) Farmasöytiske opplösninger av levosimendan
NO20001847L (no) Ny anvendelse av forbindelser for anti-kløe-aktivitet
FR2776660B1 (fr) Diazepino-indoles de phosphodiesterases iv
NO20012976L (no) Anvendelse av inhibitorer av KQTI-kanalen for fremstilling av et medikament
NO20010654L (no) Ny anvendelse av taxoidderivater
DE69905837D1 (de) Eine verdunstungsschale
NO20016151D0 (no) Fremstilling av substituerte piperidin-4-oner
NO991542L (no) Anvendelse av svake stallegeringer for antikoksing
NO20013145D0 (no) Anvendelse av Na-H-bytter-inhibitorer for fremstilling av medikamenter
NO996438D0 (no) Ny kombinasjon av astmamedikamenter
PT1178984E (pt) Derivados de 1-trifluorometil-4-hidroxi-7-piperidinilamimometilcromano
NO20012992D0 (no) Krystallinsk form av TRAP samt anvendelse derav for strukturbasert medikament-utforming
NO20003799D0 (no) Innkorporering av kolesterol-senkende midler i konfektdosisformer
NO20014845D0 (no) Anvendelse av arylalkanoylpyridaziner
NO20016030D0 (no) Derivater av 4'-demykarosyl-8a-aza-8a-homotylosin

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application